Immupharma PLC Director/PDMR Shareholding (0951A)

TIDMIMM

RNS Number : 0951A

Immupharma PLC

02 June 2016

For Immediate Release 2 June 2016

IMMUPHARMA PLC

Grant of Options

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, has today granted a total number of 1,600,000 share options to certain of its directors and employees representing 1.31% of ImmuPharma's Ordinary Shares and total voting rights. The exercise price for these options is 43.88 pence being the closing middle market share price on 1 June 2016. The options are exercisable between three and ten years from the date of grant.

The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme.

The amount of options granted to directors are summarised in the following table:

 
     Director       Options Granted 
-----------------  ---------------- 
   Tim McCarthy         500,000 
-----------------  ---------------- 
 Franco di Muzio        100,000 
-----------------  ---------------- 
  Stephane Mery         100,000 
-----------------  ----------------

Following this grant of options, the total number of share options outstanding will be 3,080,000 representing 2.53% of ImmuPharma's total voting rights.

-Ends-

 
 For further information please 
  contact: 
                                               + 44 (0) 20 
   ImmuPharma plc (www.immupharma.org)           7152 4080 
   Tim McCarthy, Chairman 
   Lisa Baderoon, Head of Investor 
    Relations                                + 44 (0) 7721 
    Twitter: @immupharma                      413 496 
 
    Panmure, Gordon & Co., NOMAD &            +44 (0) 20 7886 
    Broker                                         2500 
   Fred Walsh, Duncan Monteith, Corporate 
    Finance 
    Charles Leigh-Pemberton, Corporate 
    Broking

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFTMFTMBTMBAF

(END) Dow Jones Newswires

June 02, 2016 12:26 ET (16:26 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024